These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26752277)

  • 21. Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.
    Ortega M; Brier MR; Ances BM
    AIDS; 2015 Mar; 29(6):703-12. PubMed ID: 25849834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
    Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
    Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
    Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
    Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy.
    Garvey L; Surendrakumar V; Winston A
    HIV Clin Trials; 2011; 12(6):333-8. PubMed ID: 22189152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era.
    Cribbs SK; Tse C; Andrews J; Shenvi N; Martin GS
    Crit Care Med; 2015 Aug; 43(8):1638-45. PubMed ID: 25853590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia.
    Malagurski B; Bugarski Ignjatović V; Marić D; Nikolašević Ž; Mihić L; Brkić S
    Appl Neuropsychol Adult; 2018; 25(6):513-522. PubMed ID: 28665215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
    Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
    AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can antiretroviral therapy prevent HIV-associated cognitive disorders?
    Winston A; Vera JH
    Curr Opin HIV AIDS; 2014 Jan; 9(1):11-6. PubMed ID: 24275675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy.
    Jericó C; Knobel H; Calvo N; Sorli ML; Guelar A; Gimeno-Bayón JL; Saballs P; López-Colomés JL; Pedro-Botet J
    Stroke; 2006 Mar; 37(3):812-7. PubMed ID: 16439699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Associated with Immunological Discordance in HIV-Infected Patients Receiving Antiretroviral Therapy with Complete Viral Suppression in a Resource-Limited Setting.
    Mingbunjerdsuk P; Asdamongkol N; Sungkanuparph S
    Jpn J Infect Dis; 2015; 68(4):301-4. PubMed ID: 25720640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary].
    Lakatos B; Szabó Z; Bozzai B; Bánhegyi D; Gazdag G
    Ideggyogy Sz; 2014 Nov; 67(11-12):409-14. PubMed ID: 25720243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    Qu Y; Weinstein A; Wang Z; Cheng Y; Kingsley L; Levine A; Martin E; Munro C; Ragin AB; Rubin LH; Sacktor NW; Seaberg EC; Becker JT;
    AIDS; 2022 Jan; 36(1):19-27. PubMed ID: 34524146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.